What lab tests are included in a lupus workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lupus Laboratory Workup

A comprehensive lupus workup should include routine laboratory tests (CBC, serum creatinine, proteinuria, urinary sediment) and immunological tests (serum C3/C4, anti-dsDNA, anti-Ro/SSA, anti-La/SSB, antiphospholipid antibodies, anti-RNP) as these provide essential prognostic information for disease activity and organ involvement. 1

Initial Testing for Diagnosis

First-Line Testing

  • Anti-Nuclear Antibody (ANA): The reference method is indirect immunofluorescence assay (IIFA) on HEp-2 cells 1
    • Screening dilution typically 1:160
    • Report should include pattern and highest dilution showing reactivity
    • Sensitivity for SLE approaches 100%, but specificity is low

Second-Line Testing (if ANA positive)

  • Anti-double stranded DNA (anti-dsDNA):

    • Highly specific for SLE (40-80% of patients)
    • Preferred methods: Farr assay or Crithidia luciliae immunofluorescence test (CLIFT) for highest specificity 1, 2
    • Results should be reported quantitatively
  • Extractable Nuclear Antigens (ENA) panel:

    • Anti-Ro/SSA: Associated with photosensitivity, subacute cutaneous lupus, neonatal lupus
    • Anti-La/SSB: Often with Sjögren's features
    • Anti-Sm: Highly specific for SLE
    • Anti-RNP: Associated with mixed connective tissue disease
    • Results should be reported separately for each antigen 1

Additional Immunological Testing

  • Complement levels:

    • C3 and C4 (decreased in active disease)
    • Anti-C1q antibodies (associated with nephritis)
  • Antiphospholipid antibodies:

    • Lupus anticoagulant (LA): Requires specialized coagulation testing 1
    • Anti-cardiolipin antibodies (IgG and IgM)
    • Anti-β2 glycoprotein I antibodies

Routine Laboratory Tests

  • Complete Blood Count (CBC):

    • Hemoglobin (anemia)
    • White blood cell count (leukopenia)
    • Platelet count (thrombocytopenia)
  • Renal Function Tests:

    • Serum creatinine
    • Urinalysis with microscopic examination
    • Urine protein:creatinine ratio or 24-hour protein
    • Estimated glomerular filtration rate (eGFR)
  • Inflammatory Markers:

    • Erythrocyte sedimentation rate (ESR)
    • C-reactive protein (CRP)

Organ-Specific Testing (as indicated)

  • Renal Assessment:

    • Renal biopsy (if significant proteinuria, hematuria, or declining renal function)
  • Neurological Assessment:

    • Brain MRI (for neuropsychiatric manifestations)
    • Cerebrospinal fluid analysis

Monitoring Disease Activity

For ongoing monitoring of disease activity, the following tests are most valuable:

  • Anti-dsDNA antibody levels
  • Complement levels (C3/C4)
  • Complete blood count
  • Urinalysis and proteinuria quantification
  • Serum creatinine

Clinical Pearls and Pitfalls

  • Important caveat: ANA testing should only be performed in patients with unexplained involvement of two or more organ systems, not for nonspecific symptoms like fatigue 3, 4
  • The odds ratio for flare in asymptomatic patients with elevated anti-dsDNA is 3.0 and with low C3 is 2.0 5
  • For monitoring anti-dsDNA levels, use the same method consistently 1
  • Lupus anticoagulant testing should be performed before starting anticoagulant therapy or after discontinuation 1
  • No single laboratory test can reliably distinguish disease activity levels; combinations of tests provide better assessment 6

Special Considerations

  • Pregnancy: Additional monitoring of anti-Ro/SSA, anti-La/SSB, and antiphospholipid antibodies is crucial due to risk of neonatal lupus, congenital heart block, and pregnancy complications 1
  • Antiphospholipid syndrome: Requires testing for lupus anticoagulant, anti-cardiolipin, and anti-β2 glycoprotein I antibodies 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.